Genital chlamydial infections: Epidemiology and reproductive sequelae

American Journal of Obstetrics and Gynecology

Volumn 164, Issue 6 PART 2, 1991, Pages 1771-1781

  Cates Jr , Willard ^a,b   Wasserheit, Judith N ^a,b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

ectopic pregnancy; endometritis; nonspecific urethritis; Pelvic inflammatory disease; salpingitis

Indexed keywords

CHLAMYDIA TRACHOMATIS; CONFERENCE PAPER; ECTOPIC PREGNANCY; ENDOMETRITIS; FEMALE; FEMALE GENITAL TRACT INFECTION; HUMAN; INFERTILITY; PELVIC INFLAMMATORY DISEASE; PRIORITY JOURNAL; SALPINGITIS; URETHRITIS;

ACUTE DISEASE; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; FEMALE; GENITAL DISEASES, FEMALE; HUMAN; INFERTILITY, FEMALE; PELVIC INFLAMMATORY DISEASE; PREGNANCY; PREGNANCY, ECTOPIC; SALPINGITIS;

EID: 0025821841     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9378(91)90559-A     Document Type: Article

References (124)

1. Epidemiology and control of sexually transmitted diseases: strategic evolution
2. Chlamydia trachomitis infections in the United States: what are thev costing us?
3. Chlamydia trachomatis infections of the adult
4. Gonorrhea, chlamydia, and pelvic inflammatory disease
5. Department of Health and Social Security, England and Wales
6. Incidence of Chlamydia trachomatis infections in the United States: using reported Neisseria gonorrhoeae as a surrogate
7. Male urethritis in King County, Washington, 1974–1975: I. Incidence
8. Epidemiology and control of nongonococcal urethritis and genital chlamydial infections: a review
9. Incidence of four sexually transmitted diseases in a rural community: a prospective study
10. Epidemiologic differences between chlamydia and gonorrhea
11. Estimation of transmission probabilities for chlamydial infection
12. Chlamydia trachomatis infections policy guidelines for prevention and control
13. Chlamydial infections
14. Why we need a program for the control of Chlamydia trachomatis
15. Factors related to genital Chlamydia trachomatis and its diagnosis by culture in a sexually transmitted diseases clinic
16. Cervical Chlamydia trachomatis infection in university women: relationship to history, contraception, ectopy, and cervicitis
17. Criteria for selective screening for Chlamydia trachomatis infection in women attending family planning clinics
18. Screening for Chlamydia trachomatis infection in a sexually transmitted disease clinic: comparison of diagnostic tests with clinical and historical risk factors
19. Prevalence and epidemiologic correlates of Chlamydia trachomatis in rural and urban populations
20. Selective screening for Chlamydia trachomatis infection in a primary care population of women
21. Fifteen-month follow-up study of women infected with Chlamydia trachomatis
22. Chlamydia trachomatis urethral infections in men. Prevalence, risk factors, and clinical manifestations
23. Asymptomatic Chlamydia trachomatis urethritis in men
24. Diagnosis of Chlamydia trachomatis genitourinary infections
25. Screening for chlamydial infections in women attending family planning clinics
26. Mucopurulent cervicitis—the ignored counterpart in women of urethritis in men
27. Chlamydia trachomatis in the pharynx and rectum of heterosexual patients at risk for genital infection
28. Effect of blind passage and multiple sampling on recovery of Chlamydia trachomatis from urogenital specimens
29. Causes of the acute urethral syndrome in women
30. Comparative epidemiology of gonococcal and chlamydial infections in Baltimore STD clinic patients
31. Chlamydial and gonococcal infections in a defined population of women
32. Effect of treatment regimens for N. gonorrhoeae on simultaneous infection with C. trachomatis
33. Failure of β-lactam antibiotics to eradicate Chlamydia trachomatis in the endometrium despite apparent clinical cure of acute salpingitis
34. Association between vaginal douching and acute pelvic inflammatory disease
35. Oral contraceptives, Chlamydia trachomatis infection, and pelvic inflammatory disease: a word of caution about protection
36. The pill, chlamydia, and PID
37. Oral contraceptive use and the risk of chlamydial and gonococcal infections
38. Specific effects of estradiol on genital mucosal antibody response in chlamydial ocular and genital infections
39. Decreased risk of symptomatic chlamydial pelvic inflammatory disease associated with oral contraceptive use
40. Chlamydial salpingitis in female guinea pigs receiving oral contraceptives
41. The relationship of tubal infertility to barrier method and oral contraceptive use
42. Chlamydia trachomatis: a risk factor of persistent koilocytotic atypia
43. Sexually transmitted diseases, pelvic inflammatory disease, and infertility: an epidemiologic update
44. Microbiology of specimens obtained by laparoscopy from controls and from patients with pelvic inflammatory disease or infertility with tubal obstruction: Chlamydia trachomatis and Ureaplasma urealyticum
45. Infection with Chlamydia trachomatis, Mycoplasma hominis, and Neisseria gonorrhoeae in patients with acute pelvic inflammatory disease
46. Chlamydia trachomatis infection in patients with acute salpingitis
47. Antibodies to Chlamydia trachomatis, Mycoplasma hominis, and Neisseria gonorrhoeae in sera from patients with acute salpingitis
48. Pelvic inflammatory disease etiologic studies with emphasis on chlamydial infection
49. Morbidity associated with pelvic inflammatory disease
50. Chlamydia trachomatis infection in patients with laparoscopically verified acute salpingitis
51. Epidemiologic serodiagnostic aspects of chlamydial salpingitis
52. Chlamydia trachomatis in acute salpingitis
53. Chlamydia trachomatis in acute salpingitis
54. Serologic evidence for the role of Bacteroides fragilis and Enterobacteriaceae in the pathogenesis of acute pelvic inflammatory disease
55. Evidence of infection with C. trachomatis in patients with pelvic inflammatory disease: value of partner investigation
56. A clinical and microbiological study of laparoscopically confirmed pelvic inflammatory disease in London [Abstract]
57. Isolation of chlamydia in acute salpingitis
58. Acute pelvic inflammatory disease in outpatients and associates with Chlamydia trachomatis and Neisseria gonorrhoeae
59. Polymicrobial etiology of acute pelvic inflammatory disease
60. Etiology of acute salpingitis: influence of episode number and duration of symptoms
61. The microbiology and therapy of acute pelvic inflammatory disease in hospitalized patients
62. Acute salpingitis: diagnosis and treatment
63. Microbiology and pathogenesis of acute salpingitis as determined by laparoscopy: what is the appropriate site to sample?
64. Upper and lower reproductive tract bacteria in 126 women with acute pelvic inflammatory disease: microbial susceptibility and clinical response to four therapeutic regimens
65. Etiology and outcome of acute pelvic inflammatory disease
66. Pelvic inflammatory disease associated with Neisseria gonorrhoeae and Chlamydia trachomatis: clinical correlates
67. Atypical pelvic inflammatory disease: subacute, chronic, or subclinical upper genital tract infection in women
68. Prevalence and manifestations of endometritis among women with cervicitis
69. Comparison of endometrial biopsy and peritoneal fluid cytologic testing with laparoscopy in the diagnosis of acute pelvic inflammatory disease
70. Pelvic inflammatory disease: bacteriology and sequelae
71. Sexually transmitted diseases and infertility
72. Sexually transmitted organisms and infertility: the proof of the pudding
73. A comparison of the fallopian tube's response to overt and silent salpingitis
74. Chlamydial serology in infertile women by immunofluorescence
75. Urethritis and associated infections in Johannesburg—the role of Chlamydia trachomatis
76. Correlation between serum antichlamydial antibodies and tubal factor as a cause of infertility
77. Increased frequency of serum antibodies to Chlamydia trachomatis in infertility due to distal tube disease
78. Evidence of prior pelvic inflammatory disease and its relationship to Chlamydia trachomatis antibody and intrauterine contraceptive device use in infertile women
79. Chlamydia trachomatis infection in infertile women
80. The relationship between chlamydia antibodies and involuntary infertility
81. Chlamydial serology in fertile and infertile women
82. Evidence of chlamydial infection in infertile women with and without fallopian tube obstruction
83. Chlamydia trachomatis is not an important cause of abnormal postcoital tests in ovulating patients
84. Chlamydia trachomatis: its role in tubal infertility
85. Serological evidence that chlamydiae and mycoplasmas are involved in infertility of women
86. Chlamydial serology in women with tubal infertility
87. Seroepidemiology of Chlamydia trachomatis infection in infertile women in Melbourne
88. Residues of pelvic inflammatory disease in intrauterine device users: a result of intrauterine device or Chlamydia trachomatis infection?
89. Prevalence of antibody to Chlamydia trachomatis is spontaneous abortion and infertility
90. Infertility and chlamydial infection
91. Chlamydial antibodies and tubal infertility
92. Tubal factor infertility: an association with prior chlamydial infection and asymptomatic salpingitis
93. Chlamydial antibody, as determined with an enzyme-linked immunosorbent assay, in tubal factor infertility
94. Tubal infertility in the Gambia: chlamydial and gonococcal serology in women with tubal occlusion compared with pregnant controls
95. Prevalence of antibodies to Chlamydia trachomatis, Neisseria gonorrhoeae, and Mycoplasma hominis in infertile women
96. Chlamydial and gonococcal antibodies in sera of infertile women with tubal obstruction
97. Serologic evidence for the role of Chlamydia trachomatis, Neisseria gonorrhoeae, and Mycoplasma hominis in the etiology of tubal factor infertility and ectopic pregnancy
98. The role of Neisseria gonorrhoeae and Chlamydia trachomatis in pelvic inflammatory disease and its sequelae in Zimbabwe
99. Infertility after acute salpingitis with special reference to Chlamydia trachomatis
100. Acute pelvic inflammatory disease
101. Differences in some clinical and laboratory parameters in acute salpingitis related to culture and serologic finding
102. Unrecognized high prevalence of Chlamydia trachomatis genital infection in an isolated Alaskan eskimo population
103. Chlamydia trachomatis: a major threat to reproduction
104. High prevalence of silent chlamydia colonization of the tubal mucosa in infertile women
105. Immunopathology and histopathology of experimental chlamydial salpingitis
106. Distal tubal obstruction induced by repeated Chlamydia trachomatis salpingeal infections in pig-tailed macaques
107. Histopathology of the female reproductive tract of the pig-tailed macaque after tubal challenge following repeated cervical infection with Chlamydia trachomatis [Abstract]
108. Recovery of Chlamydia trachomatis from endometrial and fallopian tube biopsies in women with infertility of tubal origin
109. Gamma interferon mediated cytotoxicity related to murine Chlamydia trachomatis infection
110. The effect of tetracycline treatment on chlamydial salpingitis and subsequent fertility in the mouse
111. Ectopic pregnancy and antibodies to Chlamydia trachomatis
112. Chlamydia trachomatis infection in women with ectopic pregnancy
113. Serologic evidence of prior chlamydial infection in patients with tubal ectopic pregnancy and contralateral tubal disease
114. Gonococcal and chlamydial antibodies in ectopic and intrauterine pregnancy
115. Antibodies to Chlamydia trachomatis and the risk of tubal pregnancy
116. Serum Igh and IgA antibodies to Chlamydia in ectopic pregnancies
117. The association between Chlamydia trachomatis and ectopic pregnancy: a matched-pair, case-control study
118. Sexually transmitted disease and tubal pregnancy
119. Incidence, trends, and risks of ectopic pregnancy in a population of women
120. Microscopic evidence of silent inflammation in grossly normal fallopian tubes with ectopic pregnancy
121. Treatment of Chlamydia trachomatis infections of the urogenital tract
122. Regional program for widespread screening for Chlamydia trachomatis in family planning clinics